Organovo Holdings, Inc.
ONVO
Rank in Stocks
#36082
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Share Price
$2.00
Last synced: 2025-05-19
Market Cap
$2.93M
Change (1 day)
-3.38%
Change (1 year)
656.14%
Country
US
Trade Organovo Holdings, Inc. (ONVO)
Category
Healthcare
Market Capitalization of Organovo Holdings, Inc.(ONVO)
Market Cap: $2.93M
As of October 2026 Organovo Holdings, Inc. has a market cap of $2.93M. This makes Organovo Holdings, Inc. the world's 36082nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Organovo Holdings, Inc. from 2014 to 2026
ONVO compared with Top 5 Most Popular stocks
